Trial
NCT02112045
A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Washington University School of Medicine
Collaborators
—
Condition
Multiple Myeloma
Intervention
Granix
Why stopped
Terminated due to results of interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-26